Eevia Health Plc releases a new scientific article on the BioMAP study for the data and results relating to Feno-Sambucus® Organic, Eevia’s organic Elderberry extract product line
Eevia Health Plc (”Eevia” or ”The Company”) has released a scientific article on the results of the recently completed BioMAP study that was done with Eurofins. The new article only deals with results regarding the Feno-Sambucus® Organic product line, an organically certified and trade-name-protected product line of elderberry extract.The scientific article sums up the results that were achieved in the BioMAP study. BioMAP is a phenotypic profiling platform run by Eurofins. The receipt of the overall study report was reported on September 11, 2023 in the following press release: Eevia